141 related articles for article (PubMed ID: 34055363)
1.
Jesus-Ribeiro J; Pereira C; Robalo C; Pereira DJ; Duro D; Ramos F; Freire A; Melo JB
Oxf Med Case Reports; 2021 May; 2021(5):omab027. PubMed ID: 34055363
[TBL] [Abstract][Full Text] [Related]
2. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
Baulac S; Ishida S; Marsan E; Miquel C; Biraben A; Nguyen DK; Nordli D; Cossette P; Nguyen S; Lambrecq V; Vlaicu M; Daniau M; Bielle F; Andermann E; Andermann F; Leguern E; Chassoux F; Picard F
Ann Neurol; 2015 Apr; 77(4):675-83. PubMed ID: 25623524
[TBL] [Abstract][Full Text] [Related]
3.
Liu L; Chen ZR; Xu HQ; Liu DT; Mao Y; Liu HK; Liu XR; Zhou P; Lin SM; Li B; He N; Su T; Zhai QX; Meng H; Liao WP; Yi YH
Front Neurosci; 2020; 14():821. PubMed ID: 32848577
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
5. The Challenge of Somatic Variants in Focal Cortical Dysplasia.
Jesus-Ribeiro J; Pires LM; Ribeiro IP; Rebelo O; Pereira R; Sales F; Santana I; Freire A; Melo JB
Innov Clin Neurosci; 2023; 20(10-12):35-39. PubMed ID: 38193103
[TBL] [Abstract][Full Text] [Related]
6. Identification of genetic characteristics in pediatric epilepsy with focal cortical dysplasia type 2 using deep whole-exome sequencing.
Xu Y; Zhao R; Wang M; Wang XH; Wang Y; Li H; Ma YY; Wu BB; Zhou YF
Mol Genet Genomic Med; 2022 Dec; 10(12):e2086. PubMed ID: 36342087
[TBL] [Abstract][Full Text] [Related]
7. mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes.
Krochmalnek E; Accogli A; St-Onge J; Addour-Boudrahem N; Prakash G; Kim SH; Brunette-Clement T; Alhajaj G; Mougharbel L; Bruneau E; Myers KA; Dubeau F; Karamchandani J; Farmer JP; Atkinson J; Hall J; Chantal Poulin C; Rosenblatt B; Lafond-Lapalme J; Weil A; Fallet-Bianco C; Albrecht S; Sonenberg N; Riviere JB; Dudley RW; Srour M
Neurol Genet; 2023 Dec; 9(6):e200103. PubMed ID: 37900581
[TBL] [Abstract][Full Text] [Related]
8. Germline and somatic mutations in the
Møller RS; Weckhuysen S; Chipaux M; Marsan E; Taly V; Bebin EM; Hiatt SM; Prokop JW; Bowling KM; Mei D; Conti V; de la Grange P; Ferrand-Sorbets S; Dorfmüller G; Lambrecq V; Larsen LH; Leguern E; Guerrini R; Rubboli G; Cooper GM; Baulac S
Neurol Genet; 2016 Dec; 2(6):e118. PubMed ID: 27830187
[TBL] [Abstract][Full Text] [Related]
9. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy.
Ribierre T; Deleuze C; Bacq A; Baldassari S; Marsan E; Chipaux M; Muraca G; Roussel D; Navarro V; Leguern E; Miles R; Baulac S
J Clin Invest; 2018 Jun; 128(6):2452-2458. PubMed ID: 29708508
[TBL] [Abstract][Full Text] [Related]
10. DEPDC5 plays a vital role in epilepsy: Genotypic and phenotypic features in cohort and literature.
Gu C; Wei X; Yan D; Cai Y; Li D; Shu J; Cai C
Epileptic Disord; 2024 Jun; 26(3):341-349. PubMed ID: 38752894
[TBL] [Abstract][Full Text] [Related]
11. Germline homozygous missense DEPDC5 variants cause severe refractory early-onset epilepsy, macrocephaly and bilateral polymicrogyria.
Ververi A; Zagaglia S; Menzies L; Baptista J; Caswell R; Baulac S; Ellard S; Lynch S; ; Jacques TS; Chawla MS; Heier M; Kulseth MA; Mero IL; Våtevik AK; Kraoua I; Ben Rhouma H; Ben Younes T; Miladi Z; Ben Youssef Turki I; Jones WD; Clement E; Eltze C; Mankad K; Merve A; Parker J; Hoskins B; Pressler R; Sudhakar S; DeVile C; Homfray T; Kaliakatsos M; ; Robinson R; Keim SMB; Habibi I; Reymond A; Sisodiya SM; Hurst JA
Hum Mol Genet; 2023 Jan; 32(4):580-594. PubMed ID: 36067010
[TBL] [Abstract][Full Text] [Related]
12. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy.
Dawson RE; Nieto Guil AF; Robertson LJ; Piltz SG; Hughes JN; Thomas PQ
Neurobiol Dis; 2020 Feb; 134():104640. PubMed ID: 31639411
[TBL] [Abstract][Full Text] [Related]
13. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA.
Lee WS; Stephenson SEM; Howell KB; Pope K; Gillies G; Wray A; Maixner W; Mandelstam SA; Berkovic SF; Scheffer IE; MacGregor D; Harvey AS; Lockhart PJ; Leventer RJ
Ann Clin Transl Neurol; 2019 Jul; 6(7):1338-1344. PubMed ID: 31353856
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a Dual-Pathway, 2-Hit Genetic Model for Focal Cortical Dysplasia and Epilepsy.
Bennett MF; Hildebrand MS; Kayumi S; Corbett MA; Gupta S; Ye Z; Krivanek M; Burgess R; Henry OJ; Damiano JA; Boys A; Gécz J; Bahlo M; Scheffer IE; Berkovic SF
Neurol Genet; 2022 Feb; 8(1):e652. PubMed ID: 35097204
[TBL] [Abstract][Full Text] [Related]
15. Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5.
Scerri T; Riseley JR; Gillies G; Pope K; Burgess R; Mandelstam SA; Dibbens L; Chow CW; Maixner W; Harvey AS; Jackson GD; Amor DJ; Delatycki MB; Crino PB; Berkovic SF; Scheffer IE; Bahlo M; Lockhart PJ; Leventer RJ
Ann Clin Transl Neurol; 2015 May; 2(5):575-80. PubMed ID: 26000329
[TBL] [Abstract][Full Text] [Related]
16. Genomic and Epigenetic Advances in Focal Cortical Dysplasia Types I and II: A Scoping Review.
Jesus-Ribeiro J; Pires LM; Melo JD; Ribeiro IP; Rebelo O; Sales F; Freire A; Melo JB
Front Neurosci; 2020; 14():580357. PubMed ID: 33551717
[No Abstract] [Full Text] [Related]
17. Epilepsy in the mTORopathies: opportunities for precision medicine.
Moloney PB; Cavalleri GL; Delanty N
Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
[TBL] [Abstract][Full Text] [Related]
18. DEPDC5-related epilepsy: A comprehensive review.
Samanta D
Epilepsy Behav; 2022 May; 130():108678. PubMed ID: 35429726
[TBL] [Abstract][Full Text] [Related]
19. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy.
Marsan E; Baulac S
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):6-17. PubMed ID: 29359340
[TBL] [Abstract][Full Text] [Related]
20. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3.
Sim JC; Scerri T; Fanjul-Fernández M; Riseley JR; Gillies G; Pope K; van Roozendaal H; Heng JI; Mandelstam SA; McGillivray G; MacGregor D; Kannan L; Maixner W; Harvey AS; Amor DJ; Delatycki MB; Crino PB; Bahlo M; Lockhart PJ; Leventer RJ
Ann Neurol; 2016 Jan; 79(1):132-7. PubMed ID: 26285051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
